Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM
Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY
Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US

More Jobs >>

Events

Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston
Partnerships in Clinical Trials 2012
March 4-7 — Orlando, FL
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
Just Released: New Trends in Preventive and Therapeutic Vaccine

More Events >>

Related Tags >> Nabi Biopharmaceuticals Vaccine FDA

NicVAX News

Most Popular NicVAX Story

Nabi explores options after NicVAX flunks trial

November 9, 2011 — 2:51pm ET | By Maureen Martino

Nabi Biopharmaceuticals ($NABI) was hit hard earlier this week after the company's smoking cessation vaccine NicVAX flunked a second late-stage trial. Data showed the primary endpoint was not met in Read more...

NicVAX Press Releases

Nabi Biopharmaceuticals Announces Successful Final Results of NicVAX(r) Immunogenicity Study
PRESS RELEASE: Nabi Biopharmaceuticals Announces Successful Completion of NicVAX Phase 2b Trial
PRESS RELEASE: Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months

Latest Headlines

Nabi explores options after NicVAX flunks trial
November 9, 2011
NicVAX failure spells trouble for Nabi
July 21, 2011
Nabi lands $10M for anti-smoking vaccine
September 29, 2009
Nabi, FDA agree on SPA for NicVAx
December 23, 2008

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK